EUVIMEDEUVIMED entdecken
Kohortenstudie

Disparities in Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Prescription and Dispensing in the Israeli Population—A Retrospective Cohort Study

Yaara Leibovici Weissman iD, Bronislava Calvarysky, Tzippy Shochat, Zoya Korotkov, Alon Grossman, Leonard Leibovici iD, Adi Turjeman iD

Diabetes Care · 01.04.2024 · 47 (4) · 692-697

DOI: 10.2337/dc23-1652 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes Care, online erschienen am 20.02.2024. Verfasst von Yaara Leibovici Weissman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department E, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE To describe disparities in prescribing and dispensing sodium–glucose cotransporter 2 inhibitors (SGLT2i) in Israel. RESEARCH DESIGN AND METHODS This was a population-based retrospective cohort study of adults with type 2 diabetes eligible for SGLT2i treatment from 2017 to 2023. The primary outcome was the time between initial eligibility and the first prescription of SGLT2i. RESULTS Among 32,742 eligible patients, only 53% were prescribed SGLT2i. Multivariable analyses, adjusting for death as a competing risk, revealed delays in prescription were associated with older age, Arab or Bedouin ethnicity, neoplasms, acute kidney failure, falls, previous hospitalization, urinary tract infections, and dementia. Factors associated with shorter time intervals to prescription were sex (men), medium/high socioeconomic status, and residing in an intermediate or central area of Israel. CONCLUSIONS Disparities in drug prescription exist, even in a country with universal health coverage. Addressing these disparities requires improvements in health care systems, education, and alert systems to overcome barriers to evidence-based interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2AdultMaleHumansSodium-Glucose Transporter 2IsraelRetrospective StudiesDrug PrescriptionsGlucoseSodiumHypoglycemic Agents

Substanzen

Sodium-Glucose Transporter 2GlucoseSodiumHypoglycemic Agents

Autor:innen und Institutionen

  • Internal Medicine Department E, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.
  • Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Pharmacy Service, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.
  • School of Pharmacy, the Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Statistical Consultant, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.
  • Internal Medicine Department B, Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel.

ORCID-Profile: Yaara Leibovici Weissman, Leonard Leibovici, Adi Turjeman

Zitieren

APA

Weissman, Y. L., Calvarysky, B., Shochat, T., Korotkov, Z., Grossman, A., Leibovici, L., & Turjeman, A. (2024). Disparities in Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Prescription and Dispensing in the Israeli Population—A Retrospective Cohort Study. Diabetes Care, 47(4), 692-697. https://doi.org/10.2337/dc23-1652

Vancouver

Weissman YL, Calvarysky B, Shochat T, Korotkov Z, Grossman A, Leibovici L, et al. Disparities in Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Prescription and Dispensing in the Israeli Population—A Retrospective Cohort Study. Diabetes Care. 2024;47(4):692-697. doi:10.2337/dc23-1652

BibTeX
@article{Weissman2024,
  author = {Weissman, Yaara Leibovici and Calvarysky, Bronislava and Shochat, Tzippy and Korotkov, Zoya and Grossman, Alon and Leibovici, Leonard and Turjeman, Adi},
  title = {Disparities in Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitor Prescription and Dispensing in the Israeli Population—A Retrospective Cohort Study},
  journal = {Diabetes Care},
  year = {2024},
  volume = {47},
  number = {4},
  pages = {692--697},
  doi = {10.2337/dc23-1652}
}
Kostenlos starten →